Diminished Cell Proliferation Associated with the Death-protective Activity of Bcl-2*
- From the Institute of Biochemistry, University of Fribourg, Pérolles, Rue du Musée 5, CH-1700 Fribourg, Switzerland
- ‡ To whom correspondence should be addressed. Tel.: 41-37-29-86-52; Fax: 41-37-29-97-35; E-mail: christoph.borner{at}unifr.ch
Abstract
The oncogene product Bcl-2 effectively spares cells from programmed cell death (apoptosis). The molecular mechanism underlying this death-protective activity has, however, remained enigmatic. Here we show that induction of Bcl-2 expression is consistently associated with a retardation of mammalian cell proliferation due to a prolongation of the G1 phase of the cell cycle. Whereas cells lacking Bcl-2 expression die from any point of the cell cycle in response to apoptotic agents, Bcl-2-overexpressing cells accumulate in the G0/G1 phase and are protected from cell death. Co-expression of Bax, a negative regulator of Bcl-2, reverts both the cell death protective and proliferation retarding activities of Bcl-2. Moreover, a Bcl-2 mutant defective in death protection does not affect cell division. These findings indicate that Bcl-2 contributes to cell survival by diminishing the rate of cell proliferation.
Footnotes
-
↵* This work was supported by Swiss National Science Foundation Grants 31-34600.92 and 31-36152.92 and Swiss Cancer League Grant 421. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Received December 26, 1995.
- Revision received March 8, 1996.
- © 1996 by The American Society for Biochemistry and Molecular Biology, Inc.











